» Articles » PMID: 37002899

Identification of Unique α4 Chain Structure and Conserved Antiangiogenic Activity of α3NC1 Type IV Collagen in Zebrafish

Overview
Journal Dev Dyn
Publisher Wiley
Date 2023 Apr 1
PMID 37002899
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Type IV collagen is an abundant component of basement membranes in all multicellular species and is essential for the extracellular scaffold supporting tissue architecture and function. Lower organisms typically have two type IV collagen genes, encoding α1 and α2 chains, in contrast with the six genes in humans, encoding α1-α6 chains. The α chains assemble into trimeric protomers, the building blocks of the type IV collagen network. The detailed evolutionary conservation of type IV collagen network remains to be studied.

Results: We report on the molecular evolution of type IV collagen genes. The zebrafish α4 non-collagenous (NC1) domain, in contrast with its human ortholog, contains an additional cysteine residue and lacks the M93 and K211 residues involved in sulfilimine bond formation between adjacent protomers. This may alter α4 chain interactions with other α chains, as supported by temporal and anatomic expression patterns of collagen IV chains during the zebrafish development. Despite the divergence between zebrafish and human α3 NC1 domain (endogenous angiogenesis inhibitor, Tumstatin), the zebrafish α3 NC1 domain exhibits conserved antiangiogenic activity in human endothelial cells.

Conclusions: Our work supports type IV collagen is largely conserved between zebrafish and humans, with a possible difference involving the α4 chain.

References
1.
Brodsky B, Ramshaw J . The collagen triple-helix structure. Matrix Biol. 1997; 15(8-9):545-54. DOI: 10.1016/s0945-053x(97)90030-5. View

2.
LeBleu V, Sund M, Sugimoto H, Birrane G, Kanasaki K, Finan E . Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly. J Biol Chem. 2010; 285(53):41874-85. PMC: 3009915. DOI: 10.1074/jbc.M110.149534. View

3.
Kelley P, Sado Y, Duncan M . Collagen IV in the developing lens capsule. Matrix Biol. 2002; 21(5):415-23. DOI: 10.1016/s0945-053x(02)00014-8. View

4.
Zehnder A, Adams J, Santi P, Kristiansen A, Wacharasindhu C, Mann S . Distribution of type IV collagen in the cochlea in Alport syndrome. Arch Otolaryngol Head Neck Surg. 2005; 131(11):1007-13. DOI: 10.1001/archotol.131.11.1007. View

5.
Eikesdal H, Sugimoto H, Birrane G, Maeshima Y, Cooke V, Kieran M . Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proc Natl Acad Sci U S A. 2008; 105(39):15040-5. PMC: 2567489. DOI: 10.1073/pnas.0807055105. View